South32 Limited (ASX:S32)
3.050
-0.020 (-0.65%)
Aug 12, 2025, 4:10 PM AEST
Intra-Cellular Therapies Market Cap
South32 has a market cap or net worth of 13.69 billion as of August 12, 2025. Its market cap has increased by 0.79% in one year.
Market Cap
13.69B
Enterprise Value
13.79B
Revenue
10.04B
Ranking
n/a
PE Ratio
81.46
Stock Price
$3.05
Market Cap Chart
Since May 18, 2015, South32's market cap has increased from 10.91B to 13.69B, an increase of 25.44%. That is a compound annual growth rate of 2.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 13.78B | -9.98% |
Dec 31, 2024 | 15.31B | 1.87% |
Dec 29, 2023 | 15.03B | -17.63% |
Dec 30, 2022 | 18.24B | -1.92% |
Dec 31, 2021 | 18.60B | 58.25% |
Dec 31, 2020 | 11.75B | -10.42% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BHP Group | 207.46B |
Fortescue | 57.95B |
Northern Star Resources | 25.34B |
Evolution Mining | 15.36B |
Lynas Rare Earths | 11.81B |
BlueScope Steel | 10.53B |
Orica | 10.34B |
Pilbara Minerals | 7.43B |